Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.46 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.46 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | TTR | P02766 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | GFPT1 | Q06210 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | TYR | P14679 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4799720 | 1.00 | HCAR2 (0.46) | HCAR2KEAP1NFE2L2MEN1KMT2A | |
| SCHEMBL11747448 | 0.89 | HCAR2 (0.43) | HCAR2KEAP1NFE2L2MEN1KMT2A | |
| SCHEMBL11747435 | 0.89 | HCAR2 (0.43) | HCAR2KEAP1NFE2L2MEN1KMT2A | |
| Methacrylic Acid SCHEMBL28832901 | 0.88 | ALDH1A1 (0.38) | HCAR2KEAP1NFE2L2MEN1KMT2A | |
| SCHEMBL9999399 | 0.85 | HCAR2 (0.40) | HCAR2KEAP1NFE2L2MAPTALDH1A1 | |
| SCHEMBL9999396 | 0.85 | HCAR2 (0.40) | HCAR2KEAP1NFE2L2MAPTALDH1A1 | |
| SCHEMBL20010940 | 0.85 | HCAR2 (0.40) | HCAR2KEAP1NFE2L2MAPTALDH1A1 | |
| SCHEMBL12620691 | 0.81 | MAPT (0.56) | HCAR2MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL15062325 | 0.77 | HCAR2 (0.43) | HCAR2KEAP1NFE2L2MAPTALDH1A1 | |
| SCHEMBL21610096 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9624239-B2 | Protein kinase inhibitors | PHARMASCIENCE INC. (CA) | 2017-04-18 | — | — | US | disclosed |
| US-20140045833-A1 | Protein Kinase Inhibitors | PHARMASCIENCE INC. (CA) | 2014-02-13 | — | — | US | disclosed |
| US-7371890-B2 | Method for the continuous production of a compound that carries at least two functional groups | BASF AKTIENGESELLSCHAFT (DE) | 2008-05-13 | — | — | US | disclosed |
| US-20070037999-A1 | Method for isolating a homogeneous catalyst containing rhodium | BASF AKTIENGESELLSCHAFT (DE) | 2007-02-15 | — | — | US | disclosed |
| US-20070034576-A1 | Method for separating a homogeneous catalyst | BASF AKTIENGESELLSCHAFT (DE) | 2007-02-15 | — | — | US | disclosed |
| US-20060247459-A1 | Method for the hydration of a monoolefinically unsaturated compound carrying at least two functional groups | BASF AKTIENGESELLSCHAFT (DE) | 2006-11-02 | — | — | US | disclosed |
| US-20060178525-A1 | Method for the continuous production of a compound that carries at least two functional groups | BASF AKTIENGESELLSCHAFT (DE) | 2006-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140045833-A1 | Protein Kinase Inhibitors | LCK, BTK, TEC | HCAR2 4699/4885KEAP1 3325/4885NFE2L2 3136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.